GlassOnWeb.com - Glass News - Gerresheimer discontinues marginal operations Glassfiles.com
 
 HOME   DIRECTORY   NEWS   ARTICLES   BUSINESS AREA   FORUM    JOBS  
 
Sign-in | Registration
  »  Home  »  News  »  Gerresheimer discontinues marginal operations
 
AGC
 
   CONTRIBUTE
Submit your news
Submitted news

   NEWS ARCHIVES
2008
December
November
October
September
August
July
June
May
April
March
February
January
2007
2006
2005
2004
2003
2002
2001




GLASS ON WEB - news feed
 
  News


Companies
Gerresheimer discontinues marginal operations

 
* Sale of consumer healthcare business
 
* Concentration on core business of pharmaceutics and life science

Gerresheimer AG, the leading manufacturer of glass and plastic products for the pharma & life science industry, is selling its consumer healthcare business. As previously announced, the Düsseldorf company is thereby discontinuing operations which are not part of the core business of pharmaceutics and life science.

“The consumer healthcare business did not fit in with our strategy of focussing on the fields of pharmaceutics and life science. In addition, because of the lack of synergies with the core business, our return requirements for the consumer healthcare business were not fulfilled,” says Gerresheimer CEO Dr. Axel Herberg.

The consumer healthcare business, which comprises the production of toothbrushes and other interdental articles and most recently achieved annual sales of €24m, was part of the Wilden Group, which was acquired in January 2007. The purchaser is the Krallmann Group. Through the acquisition, Krallmann intends to expand its own plastic processing division and to continue the business under the traditional “Interbros” trademark. The transaction takes place with effect on 1 June 2008. The contractual parties have agreed to keep further details confidential.

Early this year, Gerresheimer already discontinued the marginal business of aluminium packaging with sales of €3.3m.

About Gerresheimer

Gerresheimer employs more than 10,800 people in 41 locations in Europe, America and Asia. In the financial year 2007, worldwide sales totalled €957.7m. The product portfolio ranges from pharmaceutical vials made of glass and plastic through to complex drug-delivery systems for the pharma & life science industry. These include sterile syringes, inhalers and other system-based approaches for safe dosage and application of medications. The Group enjoys a leading position in markets which are characterised by high technical and regulatory barriers.

Contact
Burkhard Lingenberg
Director Corporate PR & Marketing
Telephone +49 211 6181-250
Telefax +49 211 6181-241
e-mail b.lingenberg@gerresheimer.com




June 20th, 2008
Source: Gerresheimer AG


Print this article  Printer friendly version Send this article to a friend  Send to a Friend



Add a Comment

You have to be registered in order to add your comment.
If you already have an account, please sign-in to comment.




Latest news
Dec-04-08
Polynano see-Through indicator Glass
Dec-04-08
PPG to exit insulating glass sealants business - Company closing Gloucester City, N.J., facility
Dec-04-08
Pittsburgh Glass Works Announces Restructuring Activities
Dec-04-08
The Glass is Safe, But Santa’s Out There...
Dec-03-08
Tradelink Direct Signs Up to Super Spacer Dealership
Dec-03-08
TRACO New Website Wins Crystal Achievement Award
Dec-03-08
Between Heaven and Earth New Passenger Terminal for the Luxemburg Airport using OKASOLAR and KAPILUX from OKALUX GmbH
Dec-03-08
Glass Installations celebrates huge Hollywood order
Dec-03-08
Glass America Opens New Location in Jamestown, NY
Dec-03-08
Consol Spends R86m at Bellville


ADVERTISING